Embecta (NASDAQ:EMBC) Shares Cross Below 200-Day Moving Average – Here’s What Happened

Shares of Embecta Corp. (NASDAQ:EMBC) passed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $6.57 and traded as low as $6.49. Embecta shares last traded at $6.55, with a volume of 1,277,526 shares trading hands.

Analyst Ratings Changes

EMBC has been the topic of several research reports. Weiss Ratings upgraded Embecta from a “sell (d)” rating to a “sell (d+)” rating in a research report on Friday, October 9th. Zacks Research upgraded Embecta from a “strong sell” rating to a “hold” rating in a research note on Friday, July 17th. Three analysts have rated the stock with a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Reduce” and an average price target of $11.00.

Embecta Price Performance

The firm has a market capitalization of $371.69 million, a price-to-earnings ratio of 3.17 and a beta of 0.84. The company’s 50-day moving average is $5.72 and its 200-day moving average is $6.50.

Embecta (NASDAQ:EMBC) last released its quarterly earnings results on Friday, August 7th. The company reported $0.56 EPS for the quarter, topping the consensus estimate of $0.27 by $0.29. Embecta had a net margin of 8.59% and a negative return on equity of 19.25%. The business had revenue of $271.70 million during the quarter, compared to analyst estimates of $254.53 million. During the same quarter in the prior year, the firm earned $1.12 earnings per share. The company’s quarterly revenue was down 8.1% on a year-over-year basis. Embecta has set its FY 2026 guidance at 1.800-1.900 EPS. Sell-side analysts anticipate that Embecta Corp. will post 1.84 earnings per share for the current year.

Embecta Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Thursday, August 27th were paid a dividend of $0.01 per share. The ex-dividend date of this dividend was Thursday, August 27th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.6%. Embecta’s payout ratio is 2.70%.

Insider Activity at Embecta

In other news, Director Milton Mayo Morris sold 6,293 shares of the stock in a transaction on Friday, September 4th. The stock was sold at an average price of $5.88, for a total value of $37,002.84. Following the completion of the transaction, the director directly owned 53,828 shares in the company, valued at approximately $316,508.64. This represents a 10.47% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jeffrey Mann bought 20,000 shares of the stock in a transaction that occurred on Wednesday, August 12th. The shares were bought at an average cost of $4.99 per share, with a total value of $99,800.00. Following the completion of the transaction, the insider owned 262,915 shares in the company, valued at $1,311,945.85. The trade was a 8.23% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders bought 70,000 shares of company stock valued at $334,200 in the last 90 days. Insiders own 1.30% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. State of Wyoming raised its holdings in shares of Embecta by 108.1% in the 3rd quarter. State of Wyoming now owns 74,704 shares of the company’s stock worth $423,000 after acquiring an additional 38,798 shares during the last quarter. Quadrant Capital Group LLC acquired a new position in Embecta during the 3rd quarter valued at about $62,000. CWA Asset Management Group LLC increased its holdings in Embecta by 43.4% during the 3rd quarter. CWA Asset Management Group LLC now owns 537,838 shares of the company’s stock worth $3,044,000 after purchasing an additional 162,891 shares in the last quarter. GAMMA Investing LLC increased its holdings in Embecta by 101.5% during the 3rd quarter. GAMMA Investing LLC now owns 10,898 shares of the company’s stock worth $62,000 after purchasing an additional 5,490 shares in the last quarter. Finally, Krensavage Asset Management LLC increased its holdings in Embecta by 54.4% during the 2nd quarter. Krensavage Asset Management LLC now owns 1,135,340 shares of the company’s stock worth $3,701,000 after purchasing an additional 400,000 shares in the last quarter. 93.83% of the stock is currently owned by institutional investors and hedge funds.

Embecta Company Profile

Embecta Corp. (NASDAQ: EMBC) is a global diabetes-care company that develops, manufactures and sells products used to administer insulin and monitor blood glucose. Its portfolio includes pen needles, insulin syringes, safety needles and syringes, lancets, and other diabetes-management products designed for people with diabetes and the health care professionals who support them.

The company also offers digital and connected solutions intended to support diabetes management and improve the delivery of care.